CRISPR Therapeutics AG - 8-K Filing
CRISPR Therapeutics AG held its Annual General Meeting of Shareholders on June 4, 2026, where shareholders approved the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. The plan will utilize remaining shares from prior plans plus any forfeited or canceled awards. Additionally, amendments to the company's articles of association were approved, effective upon registration in Switzerland on June 5, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On June 4, 2026, at the Annual Meeting, the shareholders of the Comp, 5.07 Submission of Matters to a Vote of Security HoldersThe Annual Meeting was held on June 4, 2026, 9.01 Financial Statements and Exhibits (d) Exhibits ExhibitNumber Description 3)
Tickers: $CRSP